Voyageur Pharmaceuticals Stock Forward View
| VM Stock | CAD 0.14 -0.01 -6.67% |
An accurate short-term forecast for Voyageur Pharmaceuticals depends on understanding not just its financials, but how the market's current narrative about Voyageur Pharmaceuticals compares to actual business performance.
In recent trading, Voyageur Pharmaceuticals reflects the short-cycle RSI of 0, indicating compressed downside momentum. Readings below 20 are commonly associated with potential stabilization zones.Momentum
Sell Peaked
Oversold | Overbought |
Wall Street Target Price 0.55 |
This view connects Voyageur Pharmaceuticals headline attention with price response and peer context.
The Naive Prediction forecasted value of Voyageur Pharmaceuticals on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.45.Voyageur Pharmaceuticals after-hype prediction price | C$ 0.14 |
Hype metrics are shown as one component among forecasting, technical, analyst, and earnings context.
Voyageur |
Voyageur Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Voyageur price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Voyageur using various technical indicators. When you analyze Voyageur charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Naive Prediction Price Forecast For the 15th of March 2026
Given 90 days horizon, the Naive Prediction forecasted value of Voyageur Pharmaceuticals on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01 , mean absolute percentage error of 0.000088 , and the sum of the absolute errors of 0.45 .Please note that although there have been many attempts to predict Voyageur Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Voyageur Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Voyageur Pharmaceuticals | Voyageur Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Voyageur Pharmaceuticals uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Voyageur Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Voyageur Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.7772 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0074 |
| MAPE | Mean absolute percentage error | 0.046 |
| SAE | Sum of the absolute errors | 0.4529 |
Mean reversion opportunities in Voyageur Pharmaceuticals' arise when market prices disconnect from fundamental anchors such as earnings, book value, or historical price-to-earnings multiples.
After-Hype Price Density Analysis
Using probability distributions for Voyageur Pharmaceuticals forecasting acknowledges that no model can consistently predict Voyageur Pharmaceuticals' exact future price. The distribution approach quantifies model uncertainty and helps investors avoid overconfidence in any single forecast.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-hype price analysis for Voyageur Pharmaceuticals provides a news-conditional view of potential price outcomes. Voyageur Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 6.77, respectively. This analysis complements technical and fundamental research by adding a news-sentiment dimension to Voyageur Pharmaceuticals' price forecasting.
Current Value
The after-hype framework applied to Voyageur Pharmaceuticals assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Voyageur Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Voyageur Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Voyageur Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 6.63 | 0.00 | 0.00 | 8 Events | 1 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.14 | 0.14 | 0.00 |
|
Hype Timeline
Voyageur Pharmaceuticals is at this time traded for 0.14on TSX Venture Exchange of Canada. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Voyageur is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.11%. %. The volatility of related hype on Voyageur Pharmaceuticals is about 22639.02%, with the expected price after the next announcement by competition of 0.14. The company recorded a loss per share of 0.02. Voyageur Pharmaceuticals last dividend was issued on the 7th of March 2017. The company completed a 1:2 stock split on 7th of March 2017. Given the investment horizon of 90 days the next estimated press release will be in 8 days. Cross-verify projections for Voyageur Pharmaceuticals using Historical Fundamental Analysis of Voyageur Pharmaceuticals. The view provides historical context for the projection set.Related Hype Analysis
The peer hype comparison table for Voyageur Pharmaceuticals includes downside risk metrics such as value-at-risk and maximum drawdown for Voyageur Pharmaceuticals' competitors. providing context for assessing the relative risk profile of a Voyageur Pharmaceuticals investment.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AVCN | Avicanna | 0.00 | 7 per month | 0.00 | -0.06 | 5.56 | -5.56 | 14.52 | |
| LABS | Medipharm Labs Corp | -0.005 | 3 per month | 3.90 | 0.04 | 7.69 | -7.14 | 22.53 | |
| CWEB | Charlottes Web Holdings | 0.03 | 3 per month | 6.89 | 0.31 | 22.03 | -14.55 | 54.32 | |
| BCT | Briacell Therapeutics Corp | 0.23 | 3 per month | 0.00 | -0.08 | 9.67 | -8.88 | 98.76 | |
| PINK | Perimeter Medical Imaging | -0.03 | 2 per month | 7.24 | 0.15 | 20.00 | -14.29 | 108.27 | |
| RVX | Resverlogix Corp | 0.00 | 5 per month | 3.62 | 0.03 | 10.00 | -9.09 | 20.20 | |
| ROMJ | Rubicon Organics | -0.02 | 3 per month | 1.78 | 0.06 | 4.35 | -2.22 | 14.76 |
Other Forecasting Options for Voyageur Pharmaceuticals
The movement of Voyageur price is the central consideration for investors deciding whether to enter or hold a position. Noise in Voyageur Stock price charts can make it difficult to distinguish meaningful trends from random fluctuations.Voyageur Pharmaceuticals Related Equities
The following equities are related to Voyageur Pharmaceuticals within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Voyageur Pharmaceuticals against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Voyageur Pharmaceuticals Market Strength Events
Investors use market strength indicators for Voyageur Pharmaceuticals to evaluate how the stock performs relative to broader market trends. These indicators support more precise timing of Voyageur Pharmaceuticals positions, helping investors maximize return and minimize poorly-timed trades.
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.14 | |||
| Day Typical Price | 0.14 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.01 |
Voyageur Pharmaceuticals Risk Indicators
A careful analysis of Voyageur Pharmaceuticals' basic risk indicators helps investors understand the risk environment surrounding voyageur stock. This understanding is an essential input for forecasting Voyageur Pharmaceuticals' future price and for deciding how to manage the associated investment risk.
| Mean Deviation | 4.07 | |||
| Semi Deviation | 4.34 | |||
| Standard Deviation | 6.47 | |||
| Variance | 41.87 | |||
| Downside Variance | 52.64 | |||
| Semi Variance | 18.86 | |||
| Expected Short fall | -9.05 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Voyageur Pharmaceuticals
Coverage intensity for Voyageur Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Voyageur Pharmaceuticals Short Properties
Short sentiment tied to Voyageur Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 139.5 M | |
| Shares Float | 162.2 M |
Additional Tools for Voyageur Stock Analysis
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |